Patients may skip some breast cancer treatments says symposium
New research at the San Antonio Breast Cancer Symposium suggests tens of thousands of women could safely forgo parts of therapy without significantly lowering survival. Findings include older women skipping radiation after early tumors and limited benefit from surgery in widespread cancer, plus a potential light chemo option.
MENTIONED IN THIS ARTICLE
San Antonio
C. Kent Osborne
Baylor College of Medicine
Female libido drug stalls after FDA impasse
Sprout Pharmaceuticals faces a stalled path to approval for Flibanserin as the FDA questions if benefits justify risks amid modest effectiveness and side effects. The Raleigh based company appeals an FDA denial while noting many appeals fail. Experts cite psychological factors in most women’s sexual desire issues.
MENTIONED IN THIS ARTICLE
Washington D.C
Sprout Pharmaceuticals
Food and Drug Administration
FDA
Sprout
Raleigh
N.C
Breed Cindy
Robert Whitehead
Also Mentioned on This Page
Rou
Duke Cancer Center
Durham, N.C
Aikenstandard.com
Dlateks Aera AY
Las
Dillard’s
Dillard's
NPC
Dublin
Dillard’s Reward
Mary Jane
Biom
Vilard
Gue
Tuen Nan al
Master Tal
Masterautomotive.com
Russ Vernon
Valve.com
Adam’s]Nursery
Adam’s Nursery and Landscaping LLC
Adamsnursery.net
Adam’s Nursery and Landscaping
Cyndi's
Fornkies Og
Aiken
Cyndi’s
Laurens St